Company records / sonothera.com
SonoThera
SonoThera (sonothera.com): no confident changes recorded yet; website history since November 2026. Homepage last checked 6 November 2026.
First recorded website
Observed 6 November 2026
How it described itself
Ultrasound-Mediated Nonviral Genetic Medicine
Explore therapeutic ultrasound for non-invasive, targeted genetic medicine delivery that improves precision and biodistribution. Learn more.
Homepage
- Displayed as investors on the website
- Arch Venture Partners · Illumina Ventures · Johnson & Johnson · Vertex Ventures · Medical Excellence Capital · Lilly · RA Capital · Duquesne Family Office LLC · Foothill Ventures · ARK INVEST · VIDA Ventures · Cure Duchenne · Otsuka · UCB Ventures · SymBiosis · Vivo Capital · Leaps by Bayer
- Funding statements on the website
- SonoThera raises $125 million to run clinical trials of its gene treatment for Duchenne muscular dystrophy.
Recorded changes
No changes recorded yet. Missing observations do not mean the company has not changed.
How it describes itself
Ultrasound-Mediated Nonviral Genetic Medicine
Cite this record
StartupHistory, “SonoThera” company record, https://startuphistory.org/c/sonothera.com